Literature DB >> 31909784

Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children.

Julie Jaffray1, Char Witmer2, Sarah H O'Brien3, Rosa Diaz4, Lingyun Ji5, Emily Krava1, Guy Young1.   

Abstract

Venous thromboembolism (VTE) incidence in children has sharply increased with the majority of cases secondary to central venous catheters (CVCs). Among CVCs, the number of peripherally inserted central catheters (PICCs) placed has risen significantly. In this multicenter, prospective, observational cohort study, we enrolled patients aged 6 months to 18 years with newly placed PICCs or tunneled lines (TLs). We evaluated the incidence of VTE, central line-associated bloodstream infections (CLABSIs), and catheter malfunctions in PICCs and TLs, and risk factors of CVC-related VTE. A total of 1967 CVCs were included in the analysis. The incidence of CVC-related VTE was 5.9% ± 0.63%. The majority of the cases, 80%, were in subjects with PICCs, which had a significantly higher risk of catheter-related VTE than subjects with TLs (hazard ratio [HR] = 8.5; 95% confidence interval [CI], 3.1-23; P < .001). PICCs were significantly more likely to have a CLABSI (HR = 1.6; 95% CI, 1.2-2.2; P = .002) and CVC malfunction (HR = 2.0; 95% CI, 1.6-2.4; P < .001). Increased risk of CVC-related VTE was found in patients with a prior history of VTE (HR = 23; 95% CI, 4-127; P < .001), multilumen CVC (HR = 3.9; 95% CI, 1.8-8.9; P = .003), and leukemia (HR = 3.5; 95% CI, 1.3-9.0; P = .031). Children with PICCs had a significantly higher incidence of catheter-related VTE, CLABSI, and CVC malfunction over TLs. The results suggest that pause be taken prior to placing CVCs, especially PICCs, due to the serious complications they have been shown to cause.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 31909784     DOI: 10.1182/blood.2019002260

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Risk factors for unplanned removal of central venous catheters in hospitalized children with hematological and oncological disorders.

Authors:  Moe Miyagishima; Motoharu Hamada; Yuji Hirayama; Hideki Muramatsu; Takahisa Tainaka; Chiyoe Shirota; Akinari Hinoki; Takahiro Imaizumi; Masahiro Nakatochi; Michi Kamei; Eri Nishikawa; Nozomu Kawashima; Atsushi Narita; Nobuhiro Nishio; Seiji Kojima; Yoshiyuki Takahashi
Journal:  Int J Hematol       Date:  2022-06-21       Impact factor: 2.319

2.  A clinical study of peripherally inserted central catheter-related venous thromboembolism in patients with hematological malignancies.

Authors:  Jing Yue; Ya Zhang; Fang Xu; Ai Mi; Qiaolin Zhou; Bin Chen; Lin Shi
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

Review 3.  2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.

Authors:  Dominique Farge; Corinne Frere; Jean M Connors; Alok A Khorana; Ajay Kakkar; Cihan Ay; Andres Muñoz; Benjamin Brenner; Pedro H Prata; Dialina Brilhante; Darko Antic; Patricia Casais; María Cecilia Guillermo Esposito; Takayuki Ikezoe; Syed A Abutalib; Luis A Meillon-García; Henri Bounameaux; Ingrid Pabinger; James Douketis
Journal:  Lancet Oncol       Date:  2022-07       Impact factor: 54.433

4.  Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE).

Authors:  Katharina Thom; Anthonie W A Lensing; Ildar Nurmeev; Fanny Bajolle; Damien Bonnet; Gili Kenet; M Patricia Massicotte; Zeynep Karakas; Joseph S Palumbo; Paola Saracco; Pascal Amedro; Juan Chain; Anthony K Chan; Takanari Ikeyama; Joyce C M Lam; Cynthia Gauger; Ákos Ferenc Pap; Madhurima Majumder; Dagmar Kubitza; William T Smith; Scott D Berkowitz; Martin H Prins; Paul Monagle; Guy Young; Christoph Male
Journal:  Blood Adv       Date:  2020-10-13

5.  Efficacy of Early Prophylaxis Against Catheter-Associated Thrombosis in Critically Ill Children: A Bayesian Phase 2b Randomized Clinical Trial.

Authors:  E Vincent S Faustino; Veronika Shabanova; Leslie J Raffini; Sarah B Kandil; Simon Li; Matthew G Pinto; Jill M Cholette; Sheila J Hanson; Marianne E Nellis; Cicero T Silva; Ranjit Chima; Anjali Sharathkumar; Kimberly A Thomas; Tara McPartland; Joana A Tala; Philip C Spinella
Journal:  Crit Care Med       Date:  2021-03-01       Impact factor: 9.296

6.  Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis.

Authors:  Helen Havens Clark; Lance Ballester; Hilary Whitworth; Leslie Raffini; Char Witmer
Journal:  Blood       Date:  2022-01-20       Impact factor: 25.476

7.  Clinical characteristics and risk factors associated with ICU-acquired infections in sepsis: A retrospective cohort study.

Authors:  Yajun He; Jiqian Xu; Xiaopu Shang; Xiangzhi Fang; Chenggang Gao; Deyi Sun; Lu Yao; Ting Zhou; Shangwen Pan; Xiaojing Zou; Huaqing Shu; Xiaobo Yang; You Shang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

8.  Central venous catheter-associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice.

Authors:  Ceder H van den Bosch; Judith Spijkerman; Marc H W A Wijnen; Idske C L Kremer Hovinga; Friederike A G Meyer-Wentrup; Alida F W van der Steeg; Marianne D van de Wetering; Marta Fiocco; Indra E Morsing; Auke Beishuizen
Journal:  Support Care Cancer       Date:  2022-07-01       Impact factor: 3.359

9.  Risk of venous thromboembolism in pediatric hospitalized patients undergoing noncardiac surgery: A report from the Children's Hospital-Acquired Thrombosis consortium.

Authors:  Elizabeth T Stephens; Anh Thy H Nguyen; Julie Jaffray; Brian Branchford; Ernest K Amankwah; Neil A Goldenberg; E Vincent S Faustino; Neil A Zakai; Amy Stillings; Emily Krava; Guy Young; John H Fargo
Journal:  Res Pract Thromb Haemost       Date:  2022-10-13

10.  COVID-19 anticoagulation recommendations in children.

Authors:  Michele Loi; Brian Branchford; John Kim; Chelsea Self; Rachelle Nuss
Journal:  Pediatr Blood Cancer       Date:  2020-06-18       Impact factor: 3.838

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.